We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics detected in cirrhotic liver tissue
AI summary Read the abstract
In a proof-of-concept study, researchers detected microplastics in liver tissue from patients with cirrhosis (severe liver scarring) in Germany. Microplastic concentrations were higher in cirrhotic livers compared to healthy control tissue, suggesting that a damaged liver may accumulate more plastic particles. This is one of the first studies to find microplastics in human liver tissue, raising questions about whether they could worsen liver disease.
BACKGROUND: The contamination of ecosystem compartments by microplastics (MPs) is an ubiquitous problem. MPs have been observed in mice tissues, and recently in human blood, stool and placenta. However, two aspects remain unclear: whether MPs accumulate in peripheral organs, specifically in the liver, and if liver cirrhosis favours this process. We aimed to examine human liver tissue samples to determine whether MPs accumulate in the liver. METHODS: This proof-of-concept case series, conducted in Germany, Europe, analyzed tissue samples of 6 patients with liver cirrhosis and 5 individuals without underlying liver disease. A total of 17 samples (11 liver, 3 kidney and 3 spleen samples) were analyzed according to the final protocol. A reliable method for detection of MP particles from 4 to 30 µm in human tissue was developed. Chemical digestion of tissue samples, staining with Nile red, subsequent fluorescent microscopy and Raman spectroscopy were performed. Morphology, size and composition of MP polymers were assessed. FINDINGS: Considering the limit of detection, all liver, kidney and spleen samples from patients without underlying liver disease tested negative for MPs. In contrast, MP concentrations in cirrhotic liver tissues tested positive and showed significantly higher concentrations compared to liver samples of individuals without underlying liver disease. Six different microplastic polymers ranging from 4 to 30 µm in size were detected. INTERPRETATION: This proof-of-concept case series assessed the presence of MPs in human liver tissue and found six different MP polymers in the liver of individuals with liver cirrhosis, but not in those without underlying liver disease. Future studies are needed to evaluate whether hepatic MP accumulation represents a potential cause in the pathogenesis of fibrosis, or a consequence of cirrhosis and portal hypertension. FUNDING: No funding was received for conducting this investigator driven study.
More Papers Like This
Screening for Suspected Microplastic-like Particles in Post-Mortem Human Liver: Correlating Histopathological Alterations with Clinical Profiles
AI summary Read the abstract
Scientists examined liver tissue from 55 deceased adults and found tiny suspected microplastic particles in about 1 in 6 samples. Livers with these particles were more likely to show signs of scarring (fibrosis) and inflammation, though blood tests didn't clearly flag these changes, suggesting standard checkups might miss plastic-related liver damage. This is early evidence from real human tissue (not just animal studies), but larger studies are needed before we know how worried to be.
Detection of Time-Dependent Uptake of Microplastics by Joint Utilization of Hepatic Organoids and a 3D-Printed Carrier
AI summary Read the abstract
Scientists grew tiny lab-made liver tissues (organoids) that behave more like real livers than flat cell cultures, and found they absorbed surprising amounts of microplastic particles, nearly 40% within 48 hours. This uptake damaged liver cells and impaired their energy-producing mitochondria, suggesting microplastics may pose a real risk to liver health, not just a theoretical one.
The mechanistic nexus between microplastics and chronic liver disease: A review of current evidence
AI summary Read the abstract
Researchers reviewed the mechanisms by which microplastics accumulate in liver tissue and worsen chronic liver disease, finding that MPs activate cell death pathways, trigger oxidative stress and inflammation, promote fibrosis, and disrupt metabolic and microbial regulation — and can amplify damage from co-occurring hepatotoxic substances.
Microplastics, nanoplastics and liver disease: an emerging health concern?
AI summary Read the abstract
Researchers reviewed emerging evidence that microplastics and nanoplastics accumulate in human liver tissue at increasing concentrations over the past decade, trigger oxidative stress, fibrogenesis, and inflammation in cell and animal models, and may carry microbial pathogens and endocrine-disrupting chemicals, introducing the concept of plastic-induced liver injury as a new focus for environmental hepatology.
Links between fecal microplastics and parameters related to metabolic dysfunction-associated steatotic liver disease (MASLD) in humans: An exploratory study
AI summary Read the abstract
In this exploratory human study, researchers found links between microplastics in people's stool samples and markers of metabolic liver disease (MASLD). Participants with liver disease had different types and amounts of fecal microplastics compared to healthy individuals, along with changes in gut bacteria and liver gene expression. While the study is small, it provides early evidence that microplastic exposure in humans may be connected to liver health problems.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.